Skip to main content

Table 3 Hematology

From: Safety evaluation of allogeneic umbilical cord blood mononuclear cell therapy for degenerative conditions

Parameter

Number of patients

Before treatment

After treatment

Reference range

P value

Significance

Leukocytes (×109/L)

114

6.94 (1.57)

7.85 (2.25)

4.0-10.0

<0.001

In normal range but significantly elevated after treatment

Neutrophilic leukocytes % of total leukocytes

114

59.70 (10.39)

65.03 (13.06)

50.0-70.0

0.001

In normal range but significantly elevated after treatment

Lymphocytes % of total leukocytes

114

30.23 (9.20)

26.03 (10.32)

20.0-40.0

<0.001

In normal range but significantly decreased after treatment

RBC (×1012/L)

113

4.61 (0.51)

4.47 (0.46)

3.5-5.0

<0.001

In normal range but significantly decreased after treatment

Mean cell hemoglobin (g/L)

113

137.02 (14.54)

132.88 (13.98)

110.0-150.0

<0.001

In normal range but significantly decreased after treatment

Platelets (×109/L)

113

193.94 (47.64)

206.21 (54.52)

100.0-300.0

0.005

In normal range but significantly elevated after treatment